Quarterly ResultJul 31, 2026, 11:04 AM
Thermo Fisher H1 Revenue +8.4% to $23.0B; EPS $9.10
AI Summary
Thermo Fisher Scientific Inc. reported strong financial results for the first half of 2026, with total revenues increasing by 8.4% to $23.0 billion and diluted EPS rising to $9.10. Net income attributable to the company grew by 8.4% to $3.39 billion. The company also significantly increased its share buybacks to $4.0 billion and invested $8.87 billion in acquisitions during the period, while generating $3.32 billion in operating cash flow.
Key Highlights
- Total revenues for H1 2026 increased 8.4% to $22.999 billion.
- Net income attributable to Thermo Fisher Scientific Inc. rose 8.4% to $3.387 billion.
- Diluted earnings per share (EPS) increased to $9.10 for the first half of 2026.
- Net cash provided by operating activities was $3.317 billion, a 56.3% increase.
- Acquisitions, net of cash acquired, totaled $8.872 billion in H1 2026.
- Purchases of company common stock amounted to $4.000 billion.
- Long-term obligations increased to $39.181 billion from $35.852 billion.
- Dividends paid totaled $337 million in the first half of 2026.
Price Impact
More from TMO